Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Bio-Pathological Markers in the Diagnosis and Therapy of Cancer. | Cancers (Basel) | 2023 | 36900276 | PubTator, text mining | PubMed |
| Complementarity determining regions in SARS-CoV-2 hybrid immunity. | Front Immunol | 2023 | 36895570 | PubTator, text mining | PubMed |
| Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL. | Blood Adv | 2023 | 36877634 | PubTator, text mining | PubMed |
| A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies. | Cell Rep Med | 2023 | 36868236 | PubTator, text mining | PubMed |
| COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group. | Ann Hematol | 2023 | 36847805 | PubTator, text mining | PubMed |
| Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era? | Front Oncol | 2023 | 36845738 | PubTator, text mining | PubMed |
| Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia. | Front Immunol | 2023 | 36845129 | PubTator, text mining | PubMed |
| Secondary involvement of gallbladder by acute lymphoblastic leukemia presenting clinically as cholecystitis in a young patient: a case report. | World J Surg Oncol | 2023 | 36843105 | PubTator, text mining | PubMed |
| Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study. | Medicina (Kaunas) | 2023 | 36837525 | PubTator, text mining | PubMed |
| Genetic Lesions in Russian CLL Patients with the Most Common Stereotyped Antigen Receptors. | Genes (Basel) | 2023 | 36833459 | PubTator, text mining | PubMed |
| Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2023 | 36831635 | PubTator, text mining | PubMed |
| A History of Targeted Therapy Development and Progress in Novel-Novel Combinations for Chronic Lymphocytic Leukemia (CLL). | Cancers (Basel) | 2023 | 36831364 | PubTator, text mining | PubMed |
| Choosing between family members is always a balancing act. | Haematologica | 2023 | 36815386 | PubTator, text mining | PubMed |
| The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia. | Clin Hematol Int | 2023 | 36811764 | PubTator, text mining | PubMed |
| Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study. | Leukemia | 2023 | 36807650 | PubTator, text mining | PubMed |
| Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia. | BioDrugs | 2023 | 36795353 | PubTator, text mining | PubMed |
| Expert consensus on the management of chronic lymphocytic leukaemia in Asia. | Clin Exp Med | 2023 | 36795237 | PubTator, text mining | PubMed |
| Sialylation regulates migration in chronic lymphocytic leukemia. | Haematologica | 2023 | 36779594 | PubTator, text mining | PubMed |
| Characterization of immunoglobulin loci in the gigantic genome of Ambystoma mexicanum. | Front Immunol | 2023 | 36776846 | PubTator, text mining | PubMed |
| Next-CLL, a New Next-Generation Sequencing-Based Method for Assessment of IGHV Gene Mutational Status in Chronic Lymphoid Leukemia. | J Mol Diagn | 2023 | 36773701 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=21